(Q48271810)

10 February 2018

title

Levomepromazine receptor binding profile in human brain--implications for treatment-resistant schizophrenia (English)

1 reference

10 February 2018

0 references

4

Quirion R

1 reference

10 February 2018

author name string

Lal S

series ordinal

1

1 reference

10 February 2018

Nair NP

series ordinal

2

1 reference

10 February 2018

Cecyre D

series ordinal

3

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 June 1993

1 reference

10 February 2018

Acta Psychiatrica Scandinavica

published in

1 reference

10 February 2018

volume

87

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

380-383

1 reference

10 February 2018

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

Human brain receptor autoradiography using whole hemisphere sections: a general method that minimizes tissue artefacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

The Mechanism of Action of Novel Antipsychotic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

New Antipsychotics: Classification, Efficacy, and Adverse Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

The effect of ritanserin on treatment-resistant neuroleptic induced akathisia: case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1993.TB03391.X

10.1111/J.1600-0447.1993.TB03391.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018